An Interventional Study To Assess The Efeect Of Vayasthapana Mahakashaya Ghanavati in Perimenopausal Syndrome And QOL Of Healthy Individuals

A Single Arm Open Label Clinical Interventional Translational Research Study to Evaluate the Effect of Vayasthapana Mahakashaya Ghanavati on Perimenopausal Syndrome and Quality of Life in Healthy Individuals - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112405

Enrollment

Registered

2026-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects with symptoms of Perimenopausal syndrome(40-55 years). 2. Apparently Healthy Individuals aged between 30-40 years

Exclusion criteria

Exclusion criteria: 1. Subjects with a History of Surgical menopause (Hysterectomy, Oophorectomy). 2. Subjects under the other Hormonal Therapy. 3. Subjects diagnosed with other systemic disorders which may interfere with the course of the disease and its management. 4. Volunteers of age below 30 and above 40 years Individuals with previous history of drug allergy. 5. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Change in Greene Climacteric Scale score in Perimenopausal Syndrome subjects from baseline after interventionTimepoint: 0th day and 46th day	—

Secondary

Measure	Time frame
Change in WHOQOL-BREF score in healthy individualsTimepoint: 0th day & 46th day;Assessment of quality of life following administration of Vayasthapana Mahakashaya GhanavatiTimepoint: 0th day & 46th day	—

Countries

India

Contacts

Public ContactDr Shilpa Hajeri

Government Ayurveda Medical College and Hospital, Mysuru

dr.shreevathsa@rediffmail.com9449772701

Outcome results